论文部分内容阅读
目的:本次主要对氨溴特罗口服液在小儿支气管炎治疗的效果进行分析,为临床治疗提供依据。方法:选取我院2014年5月-2015年8月收治并已确诊支气管患儿80例,对照组患儿采用常规临床治疗,实验组患儿在常规治疗的基础上实行氨溴特罗口服溶液治疗,对两组患儿的临床治疗进行分析。结果:对照组治疗的总有效率为77.5%,实验组的总有效率为92.5%,对照组明显低于实验组的治疗效率,此外在患儿治疗改善时间上,实验组治疗改善时间明显低于对照组,P<0.05,两组数据的对比有统计学的意义。结论:临床上对支气管患儿在常规的治疗基础上给予氨溴特罗口服溶液治疗不仅缩短了患儿的治疗时间,而且毒副作用小,安全性和可靠性高,提高了患儿的生活质量,值得在临床上推广。
OBJECTIVE: This study mainly analyzed the effect of ambroxol oral solution in the treatment of pediatric bronchitis and provided the basis for clinical treatment. Methods: 80 cases of bronchial children admitted to our hospital from May 2014 to August 2015 were selected, and the control group was treated with routine clinical treatment. The children in experimental group were treated with ambroxol oral solution Treatment, the clinical treatment of two groups of children were analyzed. Results: The total effective rate of the control group was 77.5%, the total effective rate of the experimental group was 92.5%, the control group was significantly lower than the experimental group, in addition, the improvement time of the treatment group was significantly lower In the control group, P <0.05, the two groups of data was statistically significant. Conclusion: The clinical application of oral administration of ambroxol to bronchial patients on the basis of routine treatment not only shortens the treatment time of children, but also has small toxic and side effects, high safety and reliability, and improves the quality of life of children , It is worth clinical promotion.